The tumor-associated marker, PVRL4 (Nectin-4), is the epithelial receptor for morbilliviruses

Viruses

Volumn 6, Issue 6, 2014, Pages 2268-2286

  Delpeut, Sebastien ^a,b   Noyce, Ryan S ^a,b   Richardson, Christopher D ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Canadian Center for Vaccinology Dalhousie University Halifax   (Canada)

Author keywords

Cancer; Canine distemper virus; Epithelial receptor; Measles virus; Morbillivirus; Nectin 4; Peste des petits ruminants virus; PVRL4

Indexed keywords

CD150 ANTIGEN; GLYCOPROTEIN; MEASLES VACCINE; MEMBRANE COFACTOR PROTEIN; NECTIN 4; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; LNIR PROTEIN, HUMAN; ONCOLYTIC VIRUS; TUMOR MARKER; VIRUS RECEPTOR;

ADENOCARCINOMA; AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER THERAPY; CANINE DISTEMPER MORBILLIVIRUS; DENDRITIC CELL; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE; MEASLES VIRUS; MICROSCOPY; MORBILLIVIRUS INFECTION; NEUTROPHIL; NONHUMAN; ONCOLYTIC VIROTHERAPY; PATHOGENESIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; TUMOR IMMUNITY; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS RELEASE; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; MORBILLIVIRUS; NEOPLASMS; PHYSIOLOGY; VIROLOGY;

ANIMALS; CELL ADHESION MOLECULES; EPITHELIAL CELLS; HUMANS; MEASLES VIRUS; MORBILLIVIRUS; MORBILLIVIRUS INFECTIONS; NEOPLASMS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; RECEPTORS, VIRUS; TUMOR MARKERS, BIOLOGICAL; VIRUS INTERNALIZATION;

EID: 84901926679     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v6062268     Document Type: Article

References (125)

1. McChesney, M.B.; Miller, C.J.; Rota, P.A.; Zhu, Y.D.; Antipa, L.; Lerche, N.W.; Ahmed, R.; Bellini, W.J. Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology 1997, 233, 74-84.
2. Appel, M.J. Distemper pathogenesis in dogs. J. Am. Vet. Med. Assoc. 1970, 156, 1681-1684.
3. Barrett, T. Morbillivirus infections, with special emphasis on morbilliviruses of carnivores. Vet. Microbiol. 1999, 69, 3-13.
4. Deem, S.L.; Spelman, L.H.; Yates, R.A.; Montali, R.J. Canine distemper in terrestrial carnivores: A review. J. Zoo Wildl. Med. 2000, 31, 441-451.
5. Banyard, A.C.; Parida, S.; Batten, C.; Oura, C.; Kwiatek, O.; Libeau, G. Global distribution of peste des petits ruminants virus and prospects for improved diagnosis and control. J. Gen. Virol. 2010, 91, 2885-2897.
6. Griffin, D.E.; Knipe, D.M.; Lamb, R.A.; Martin, M.A.; Roizman, B.; Straus, S.E. Measles Virus. In fields Virology, 5th ed; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2007; pp. 1551-1586.
7. Beineke, A.; Puff, C.; Seehusen, F.; Baumgartner, W., Pathogenesis and immunopathology of systemic and nervous canine distemper. Vet. Immunol. Immunopathol. 2009, 127, 1-18.
8. De Vries, R.D.; Mesman, A.W.; Geijtenbeek, T.B.; Duprex, W.P.; de Swart, R.L. The pathogenesis of measles. Curr. Opin. Virol. 2012, 2, 248-255.
9. Avota, E.; Gassert, E.; Schneider-Schaulies, S. Measles virus-induced immunosuppression: From effectors to mechanisms. Med. Microbiol. Immunol. 2010, 199, 227-237.
10. Beckford, A.P.; Kaschula, R.O.; Stephen, C. Factors associated with fatal cases of measles. A retrospective autopsy study. S Afr. Med. J. 1985, 68, 858-863.
11. Cosby, S.L.; Duprex, W.P.; Hamill, L.A.; Ludlow, M.; McQuaid, S. Approaches in the understanding of morbillivirus neurovirulence. J. Neurovirol. 2002, 8 (Suppl. 2), 85-90.
12. Wichmann, O.; Siedler, A.; Sagebiel, D.; Hellenbrand, W.; Santibanez, S.; Mankertz, A.; Vogt, G.; Treeck, U.; Krause, G. Further efforts needed to achieve measles elimination in Germany: results of an outbreak investigation. Bull. World Health Organ. 2009, 87, 108-115.
13. Carabin, H.; Edmunds, W.J.; Kou, U.; van den Hof, S.; Nguyen, V.H. The average cost of measles cases and adverse events following vaccination in industrialised countries. BMC Public Health 2002, 2, doi:10.1186/1471-2458-2-22.
14. Filia, A.; Tavilla, A.; Bella, A.; Magurano, F.; Ansaldi, F.; Chironna, M.; Nicoletti, L.; Palu, G.; Iannazzo, S.; Declich, S.; et al. Measles in Italy, July 2009 to September 2010. Euro. Surveill. 2011, 16, pii: 19925.
15. Abubakar, M.; Munir, M. Peste des Petits Ruminants Virus: An Emerging Threat to Goat Farming in Pakistan. Transbound. Emerg. Dis. 2014, doi:10.1111/tbed.12192.
16. Libeau, G.; Diallo, A.; Parida, S., Evolutionary genetics underlying the spread of peste des petits ruminants virus. Animal Frontiers 2014, 4, 14-20.
17. Ortega-Sanchez, I.R.; Vijayaraghavan, M.; Barskey, A.E.; Wallace, G.S. The economic burden of sixteen measles outbreaks on United States public health departments in 2011. Vaccine 2014, 32, 1311-1317.
18. Noyce, R.S.; Delpeut, S.; Richardson, C.D. Dog nectin-4 is an epithelial cell receptor for canine distemper virus that facilitates virus entry and syncytia formation. Virology 2013, 436, 210-220.
19. Birch, J.; Juleff, N.; Heaton, M.P.; Kalbfleisch, T.; Kijas, J.; Bailey, D. Characterization of ovine Nectin-4, a novel peste des petits ruminants virus receptor. J. Virol. 2013, 87, 4756-4761.
20. Pratakpiriya, W.; Seki, F.; Otsuki, N.; Sakai, K.; Fukuhara, H.; Katamoto, H.; Hirai, T.; Maenaka, K.; Techangamsuwan, S.; Lan, N.T.; et al. Nectin4 is an epithelial cell receptor for canine distemper virus and involved in neurovirulence. J. Virol. 2012, 86, 10207-10210.
21. Noyce, R.S.; Bondre, D.G.; Ha, M.N.; Lin, L.T.; Sisson, G.; Tsao, M.S.; Richardson, C.D. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog. 2011, 7, e1002240.
22. Muhlebach, M.D.; Mateo, M.; Sinn, P.L.; Prufer, S.; Uhlig, K.M.; Leonard, V.H.; Navaratnarajah, C.K.; Frenzke, M.; Wong, X.X.; Sawatsky, B.; et al. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 2011, 480, 530-533.
23. Tatsuo, H.; Ono, N.; Yanagi, Y. Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors. J. Virol. 2001, 75, 5842-5850.
24. Hsu, E.C.; Iorio, C.; Sarangi, F.; Khine, A.A.; Richardson, C.D. CDw150(SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus. Virology 2001, 279, 9-21.
25. Tatsuo, H.; Ono, N.; Tanaka, K.; Yanagi, Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000, 406, 893-897.
26. Dorig, R.E.; Marcil, A.; Chopra, A.; Richardson, C.D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993, 75, 295-305.
27. Naniche, D.; Varior-Krishnan, G.; Cervoni, F.; Wild, T.F.; Rossi, B.; Rabourdin-Combe, C.; Gerlier, D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 1993, 67, 6025-6032.
28. Baker, K.A.; Dutch, R.E.; Lamb, R.A.; Jardetzky, T.S. Structural basis for paramyxovirus-mediated membrane fusion. Mol. Cell 1999, 3, 309-319.
29. Colman, P.M.; Lawrence, M.C. The structural biology of type I viral membrane fusion. Nat. Rev. Mol. Cell. Biol. 2003, 4, 309-319.
30. Hernandez, L.D.; Hoffman, L.R.; Wolfsberg, T.G.; White, J.M. Virus-cell and cell-cell fusion. Annu Rev. Cell Dev. Biol. 1996, 12, 627-661.
31. Takimoto, T.; Taylor, G.L.; Connaris, H.C.; Crennell, S.J.; Portner, A. Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion. J. Virol. 2002, 76, 13028-13033.
32. Cocks, B.G.; Chang, C.C.; Carballido, J.M.; Yssel, H.; de Vries, J.E.; Aversa, G. A novel receptor involved in T-cell activation. Nature 1995, 376, 260-263.
33. Sidorenko, S.P.; Clark, E.A., Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. J. Immunol 1993, 151, 4614-4624.
34. Von Messling, V.; Milosevic, D.; Cattaneo, R. Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc. Natl Acad Sci USA 2004, 101, 14216-14221.
35. Lemon, K.; de Vries, R.D.; Mesman, A.W.; McQuaid, S.; van Amerongen, G.; Yuksel, S.; Ludlow, M.; Rennick, L.J.; Kuiken, T.; Rima, B.K.; et al. Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog. 2011, 7, e1001263.
36. De Swart, R.L.; Ludlow, M.; de Witte, L.; Yanagi, Y.; van Amerongen, G.; McQuaid, S.; Yuksel, S.; Geijtenbeek, T.B.; Duprex, W.P.; Osterhaus, A.D. Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog. 2007, 3, e178.
37. Sawatsky, B.; Wong, X.X.; Hinkelmann, S.; Cattaneo, R.; von Messling, V. Canine distemper virus epithelial cell infection is required for clinical disease but not for immunosuppression. J. Virol. 2012, 86, 3658-3666.
38. Fischer, C.D.; Ikuta, N.; Canal, C.W.; Makiejczuk, A.; Allgayer Mda, C.; Cardoso, C.H.; Lehmann, F.K.; Fonseca, A.S.; Lunge, V.R. Detection and differentiation of field and vaccine strains of canine distemper virus using reverse transcription followed by nested real time PCR (RT-nqPCR) and RFLP analysis. J. Virol. Methods 2013, 194, 39-45.
39. Kim, D.; Jeoung, S.Y.; Ahn, S.J.; Lee, J.H.; Pak, S.I.; Kwon, H.M. Comparison of tissue and fluid samples for the early detection of canine distemper virus in experimentally infected dogs. J. Vet. Med. Sci. 2006, 68, 877-879.
40. Liu, W.; Wu, X.; Wang, Z.; Bao, J.; Li, L.; Zhao, Y.; Li, J. Virus excretion and antibody dynamics in goats inoculated with a field isolate of peste des petits ruminants virus. Transbound. Emerg. Dis. 2013, 60 (Suppl. 2), 63-68.
41. Rota, P.A.; Khan, A.S.; Durigon, E.; Yuran, T.; Villamarzo, Y.S.; Bellini, W.J. Detection of measles virus RNA in urine specimens from vaccine recipients. J. Clin. Microbiol. 1995, 33, 2485-2488.
42. Saito, T.B.; Alfieri, A.A.; Wosiacki, S.R.; Negrao, F.J.; Morais, H.S.; Alfieri, A.F. Detection of canine distemper virus by reverse transcriptase-polymerase chain reaction in the urine of dogs with clinical signs of distemper encephalitis. Res. Vet. Sci. 2006, 80, 116-119.
43. Scheifele, D.W.; Forbes, C.E. Prolonged giant cell excretion in severe African measles. Pediatrics 1972, 50, 867-873.
44. Cleaveland, S.; Appel, M.G.; Chalmers, W.S.; Chillingworth, C.; Kaare, M.; Dye, C. Serological and demographic evidence for domestic dogs as a source of canine distemper virus infection for Serengeti wildlife. Vet. Microbiol. 2000, 72, 217-227.
45. Qiu, W.; Zheng, Y.; Zhang, S.; Fan, Q.; Liu, H.; Zhang, F.; Wang, W.; Liao, G.; Hu, R. Canine distemper outbreak in rhesus monkeys, China. Emerg. Infect. Dis. 2011, 17, 1541-1543.
46. Sun, Z.; Li, A.; Ye, H.; Shi, Y.; Hu, Z.; Zeng, L. Natural infection with canine distemper virus in hand-feeding Rhesus monkeys in China. Vet. Microbiol. 2010, 141, 374-378.
47. Yoshikawa, Y.; Ochikubo, F.; Matsubara, Y.; Tsuruoka, H.; Ishii, M.; Shirota, K.; Nomura, Y.; Sugiyama, M.; Yamanouchi, K. Natural infection with canine distemper virus in a Japanese monkey (Macaca fuscata). Vet. Microbiol. 1989, 20, 193-205.
48. Schneider-Schaulies, J. Cellular receptors for viruses: links to tropism and pathogenesis. J. Gen. Virol. 2000, 81, 1413-1429.
49. Uhlen, M.; Oksvold, P.; Fagerberg, L.; Lundberg, E.; Jonasson, K.; Forsberg, M.; Zwahlen, M.; Kampf, C.; Wester, K.; Hober, S.; Wernerus, H.; Bjorling, L.; Ponten, F., Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 2010, 28, 1248-1250. Available online: http://www.proteinatlas.org (accessed on 12 May 2013).
50. Tahara, M.; Takeda, M.; Shirogane, Y.; Hashiguchi, T.; Ohno, S.; Yanagi, Y. Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J. Virol 2008, 82, 4630-4637.
51. Ludlow, M.; Rennick, L.J.; Sarlang, S.; Skibinski, G.; McQuaid, S.; Moore, T.; de Swart, R.L.; Duprex, W.P. Wild-type measles virus infection of primary epithelial cells occurs via the basolateral surface without syncytium formation or release of infectious virus. J. Gen. Virol. 2010, 91, 971-979.
52. Leonard, V.H.; Sinn, P.L.; Hodge, G.; Miest, T.; Devaux, P.; Oezguen, N.; Braun, W.; McCray, P.B., Jr.; McChesney, M.B.; Cattaneo, R. Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. J. Clin. Invest. 2008, 118, 2448-2458.
53. Sinn, P.L.; Williams, G.; Vongpunsawad, S.; Cattaneo, R.; McCray, P.B., Jr. Measles virus preferentially transduces the basolateral surface of well-differentiated human airway epithelia. J. Virol. 2002, 76, 2403-2409.
54. Ludlow, M.; Lemon, K.; de Vries, R.D.; McQuaid, S.; Millar, E.L.; van Amerongen, G.; Yuksel, S.; Verburgh, R.J.; Osterhaus, A.D.; de Swart, R.L.; et al. Measles virus infection of epithelial cells in the macaque upper respiratory tract is mediated by subepithelial immune cells. J. Virol. 2013, 87, 4033-4042.
55. Frenzke, M.; Sawatsky, B.; Wong, X.X.; Delpeut, S.; Mateo, M.; Cattaneo, R.; von Messling, V. Nectin-4-dependent measles virus spread to the cynomolgus monkey tracheal epithelium: Role of infected immune cells infiltrating the lamina propria. J. Virol. 2013, 87, 2526-2534.
56. Ludlow, M.; de Vries, R.D.; Lemon, K.; McQuaid, S.; Millar, E.; van Amerongen, G.; Yuksel, S.; Verburgh, R.J.; Osterhaus, A.D.; de Swart, R.L.; et al. Infection of lymphoid tissues in the macaque upper respiratory tract contributes to the emergence of transmissible measles virus. J. Gen. Virol. 2013, 94, 1933-1944.
57. Blau, D.M.; Compans, R.W. Entry and release of measles virus are polarized in epithelial cells. Virology 1995, 210, 91-99.
58. Blau, D.M.; Compans, R.W. Adaptation of measles virus to polarized epithelial cells: Alterations in virus entry and release. Virology 1997, 231, 281-289.
59. Maisner, A.; Klenk, H.; Herrler, G. Polarized budding of measles virus is not determined by viral surface glycoproteins. J. Virol. 1998, 72, 5276-5278.
60. Naim, H.Y.; Ehler, E.; Billeter, M.A. Measles virus matrix protein specifies apical virus release and glycoprotein sorting in epithelial cells. Embo J. 2000, 19, 3576-3585.
61. Couacy-Hymann, E.; Bodjo, C.; Danho, T.; Libeau, G.; Diallo, A. Evaluation of the virulence of some strains of peste-des-petits-ruminants virus (PPRV) in experimentally infected West African dwarf goats. Vet. J. 2007, 173, 178-183.
62. Hammouchi, M.; Loutfi, C.; Sebbar, G.; Touil, N.; Chaffai, N.; Batten, C.; Harif, B.; Oura, C.; El Harrak, M., Experimental infection of alpine goats with a Moroccan strain of peste des petits ruminants virus (PPRV). Vet. Microbiol. 2012, 160, 240-244.
63. Ward, S.V.; George, C.X.; Welch, M.J.; Liou, L.Y.; Hahm, B.; Lewicki, H.; de la Torre, J.C.; Samuel, C.E.; Oldstone, M.B. RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis. Proc. Natl. Acad. Sci. USA 2011, 108, 331-336.
64. Kurita, S.; Ogita, H.; Takai, Y. Cooperative role of nectin-nectin and nectin-afadin interactions in formation of nectin-based cell-cell adhesion. J. Biol. Chem. 2011, 286, 36297-3303.
65. Takai, Y.; Miyoshi, J.; Ikeda, W.; Ogita, H. Nectins and nectin-like molecules: Roles in contact inhibition of cell movement and proliferation. Nat. Rev. Mol. Cell Biol. 2008, 9, 603-615.
66. Takai, Y.; Ikeda, W.; Ogita, H.; Rikitake, Y. The immunoglobulin-like cell adhesion molecule nectin and its associated protein afadin. Annu. Rev. Cell Dev. Biol. 2008, 24, 309-342.
67. Mendelsohn, C.L.; Wimmer, E.; Racaniello, V.R. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 1989, 56, 855-865.
68. Campadelli-Fiume, G.; Cocchi, F.; Menotti, L.; Lopez, M., The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev. Med. Virol. 2000, 10, 305-319.
69. Fabre, S.; Reymond, N.; Cocchi, F.; Menotti, L.; Dubreuil, P.; Campadelli-Fiume, G.; Lopez, M. Prominent role of the Ig-like V domain in trans-interactions of nectins. Nectin3 and nectin 4 bind to the predicted C-C'-C"-D beta-strands of the nectin1 V domain. J. Biol. Chem. 2002, 277, 27006-27013.
70. Satoh-Horikawa, K.; Nakanishi, H.; Takahashi, K.; Miyahara, M.; Nishimura, M.; Tachibana, K.; Mizoguchi, A.; Takai, Y. Nectin-3, a new member of immunoglobulin-like cell adhesion molecules that shows homophilic and heterophilic cell-cell adhesion activities. J. Biol. Chem. 2000, 275, 10291-10299.
71. Reymond, N.; Fabre, S.; Lecocq, E.; Adelaide, J.; Dubreuil, P.; Lopez, M. Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with nectin1/PRR1 through V domain interaction. J. Biol. Chem. 2001, 276, 43205-43215.
72. Yasumi, M.; Shimizu, K.; Honda, T.; Takeuchi, M.; Takai, Y. Role of each immunoglobulin-like loop of nectin for its cell-cell adhesion activity. Biochem. Biophys. Res. Commun. 2003, 302, 61-66.
73. Mizoguchi, A.; Nakanishi, H.; Kimura, K.; Matsubara, K.; Ozaki-Kuroda, K.; Katata, T.; Honda, T.; Kiyohara, Y.; Heo, K.; Higashi, M. et al. Nectin: An adhesion molecule involved in formation of synapses. J. Cell Biol. 2002, 156, 555-565.
74. Ono, N.; Tatsuo, H.; Tanaka, K.; Minagawa, H.; Yanagi, Y. V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor. J. Virol. 2001, 75, 1594-1600.
75. Delpeut, S.; Noyce, R.S.; Richardson, C.D. The V domain of dog PVRL4 (nectin-4) mediates canine distemper virus entry and virus cell-to-cell spread. Virology 2014, 454-455, 109-117.
76. Zhang, X.; Lu, G.; Qi, J.; Li, Y.; He, Y.; Xu, X.; Shi, J.; Zhang, C.W.; Yan, J.; Gao, G.F. Structure of measles virus hemagglutinin bound to its epithelial receptor nectin-4. Nat. Struct. Mol. Biol. 2013, 20, 67-72.
77. Harrison, O.J.; Vendome, J.; Brasch, J.; Jin, X.; Hong, S.; Katsamba, P.S.; Ahlsen, G.; Troyanovsky, R.B.; Troyanovsky, S.M.; Honig, B. et al. Nectin ectodomain structures reveal a canonical adhesive interface. Nat. Struct. Mol. Biol. 2012, 19, 906-915.
78. Drumond, A.; Ashton, B.; Buxton, S.; Cheung, M.; Heled, J.; Kearse, M.; Moir, R.; Stones-Havas, S.; Sturrock, S.; Thierer, T.; Wilson, A., Geneious v5.0. Available online: http://www.geneious.com (accessed on 1 March 2014).
79. Bieringer, M.; Han, J.W.; Kendl, S.; Khosravi, M.; Plattet, P.; Schneider-Schaulies, J. Experimental adaptation of wild-type canine distemper virus (CDV) to the human entry receptor CD150. PLoS One 2013, 8, e57488.
80. Sakai, K.; Yoshikawa, T.; Seki, F.; Fukushi, S.; Tahara, M.; Nagata, N.; Ami, Y.; Mizutani, T.; Kurane, I.; Yamaguchi, R. et al. Canine distemper virus associated with a lethal outbreak in monkeys can readily adapt to use human receptors. J. Virol. 2013, 87, 7170-7175.
81. Otsuki, N.; Sekizuka, T.; Seki, F.; Sakai, K.; Kubota, T.; Nakatsu, Y.; Chen, S.; Fukuhara, H.; Maenaka, K.; Yamaguchi, R. et al. Canine distemper virus with the intact C protein has the potential to replicate in human epithelial cells by using human nectin4 as a receptor. Virology 2013, 435, 485-492.
82. De Vries, R.D.; Ludlow, M.; Verburgh, R.J.; van Amerongen, G.; Yuksel, S.; Nguyen, D.T.; McQuaid, S.; Osterhaus, A.D.; Duprex, W.P.; de Swart, R.L. Measles Vaccination of Non-Human Primates Provides Partial Protection against Infection with Canine Distemper Virus. J. Virol. 2014, 88, 4423-4433.
83. Beauverger, P.; Buckland, R.; Wild, T.F. Measles virus antigens induce both type-specific and canine distemper virus cross-reactive cytotoxic T lymphocytes in mice: localization of a common Ld-restricted nucleoprotein epitope. J. Gen. Virol. 1993, 74, 2357-2363.
84. Beauverger, P.; Chadwick, J.; Buckland, R.; Wild, T.F. Serotype-specific and canine distemper virus cross-reactive H-2Kk-restricted cytotoxic T lymphocyte epitopes in the measles virus nucleoprotein. Virology 1994, 203, 172-177.
85. Stephenson, J.R.; Ter Meulen, V. Antigenic relationships between measles and canine distemper viruses: Comparison of immune response in animals and humans to individual virus-specific polypeptides. Proc. Natl. Acad. Sci. USA 1979, 76, 6601-6605.
86. Knuchel, M.C.; Marty, R.R.; Morin, T.N.; Ilter, O.; Zuniga, A.; Naim, H.Y. Relevance of a pre-existing measles immunity prior immunization with a recombinant measles virus vector. Hum. Vaccin. Immunother. 2013, 9, 23241.
87. Lorin, C.; Mollet, L.; Delebecque, F.; Combredet, C.; Hurtrel, B.; Charneau, P.; Brahic, M.; Tangy, F. A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV. J. Virol. 2004, 78, 146-157.
88. Msaouel, P.; Opyrchal, M.; Domingo Musibay, E.; Galanis, E. Oncolytic measles virus strains as novel anticancer agents. Expert Opin. Biol. Ther. 2013, 13, 483-502.
89. Rager-Zisman, B.; Bazarsky, E.; Skibin, A.; Chamney, S.; Belmaker, I.; Shai, I.; Kordysh, E.; Griffin, D.E. The effect of measles-mumps-rubella (MMR) immunization on the immune responses of previously immunized primary school children. Vaccine 2003, 21, 2580-2588.
90. Singh, M.; Cattaneo, R.; Billeter, M.A. A recombinant measles virus expressing hepatitis B virus surface antigen induces humoral immune responses in genetically modified mice. J. Virol. 1999, 73, 4823-4828.
91. Wong-Chew, R.M.; Beeler, J.A.; Audet, S.; Santos, J.I. Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine. J. Med. Virol. 2003, 70, 276-280.
92. Nakamura, T.; Russell, S.J. Oncolytic measles viruses for cancer therapy. Expert Opin. Biol. Ther 2004, 4, 1685-1692.
93. Bazan-Peregrino, M.; Sainson, R.C.; Carlisle, R.C.; Thoma, C.; Waters, R.A.; Arvanitis, C.; Harris, A.L.; Hernandez-Alcoceba, R.; Seymour, L.W. Combining virotherapy and angiotherapy for the treatment of breast cancer. Cancer Gene Ther. 2013, 20, 461-468.
94. Bluming, A.Z.; Ziegler, J.L. Regression of Burkitt's lymphoma in association with measles infection. Lancet 1971, 2, 105-106.
95. Taqi, A.M.; Abdurrahman, M.B.; Yakubu, A.M.; Fleming, A.F. Regression of Hodgkin's disease after measles. Lancet 1981, 1, doi:10.1016/S0140-6736(81)92286-8.
96. Nagy, N.; Cerboni, C.; Mattsson, K.; Maeda, A.; Gogolak, P.; Sumegi, J.; Lanyi, A.; Szekely, L.; Carbone, E.; Klein, G. et al. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines. Int. J. Cancer 2000, 88, 439-447.
97. Parrula, C.; Fernandez, S.A.; Zimmerman, B.; Lairmore, M.; Niewiesk, S. Measles virotherapy in a mouse model of adult T-cell leukaemia/lymphoma. J. Gen. Virol. 2011, 92, 1458-1466.
98. Grote, D.; Russell, S.J.; Cornu, T.I.; Cattaneo, R.; Vile, R.; Poland, G.A.; Fielding, A.K. Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood 2001, 97, 3746-3754.
99. Seya, T.; Taniguchi, M.; Matsumoto, M. [Membrane cofactor protein (MCP, CD46)]. Nihon Rinsho 1999, 57, 75-78.
100. Ong, H.T.; Timm, M.M.; Greipp, P.R.; Witzig, T.E.; Dispenzieri, A.; Russell, S.J.; Peng, K.W. Oncolytic measles virus targets high CD46 expression on multiple myeloma cells. Exp. Hematol. 2006, 34, 713-720.
101. Bjorge, L.; Hakulinen, J.; Wahlstrom, T.; Matre, R.; Meri, S. Complement-regulatory proteins in ovarian malignancies. Int. J. Cancer 1997, 70, 14-25.
102. Varsano, S.; Rashkovsky, L.; Shapiro, H.; Radnay, J. Cytokines modulate expression of cell-membrane complement inhibitory proteins in human lung cancer cell lines. Am. J. Respir. Cell Mol. Biol. 1998, 19, 522-529.
103. Blok, V.T.; Daha, M.R.; Tijsma, O.M.; Weissglas, M.G.; van den Broek, L.J.; Gorter, A. A possible role of CD46 for the protection in vivo of human renal tumor cells from complement-mediated damage. Lab. Invest. 2000, 80, 335-344.
104. Simpson, K.L.; Jones, A.; Norman, S.; Holmes, C.H. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease. Am. J. Pathol. 1997, 151, 1455-1467.
105. Kinugasa, N.; Higashi, T.; Nouso, K.; Nakatsukasa, H.; Kobayashi, Y.; Ishizaki, M.; Toshikuni, N.; Yoshida, K.; Uematsu, S.; Tsuji, T. Expression of membrane cofactor protein (MCP, CD46) in human liver diseases. Br. J. Cancer 1999, 80, 1820-1825.
106. Juhl, H.; Helmig, F.; Baltzer, K.; Kalthoff, H.; Henne-Bruns, D.; Kremer, B. Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A. J. Surg. Oncol. 1997, 64, 222-230.
107. Anderson, B.D.; Nakamura, T.; Russell, S.J.; Peng, K.W., High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Cancer Res. 2004, 64, 4919-4926.
108. Peng, K.W.; TenEyck, C.J.; Galanis, E.; Kalli, K.R.; Hartmann, L.C.; Russell, S.J. Intraperitoneal therapy of ovarian cancer using an engineered measles virus. Cancer Res. 2002, 62, 4656-4662.
109. Fabre-Lafay, S.; Garrido-Urbani, S.; Reymond, N.; Goncalves, A.; Dubreuil, P.; Lopez, M. Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-alpha-converting enzyme (TACE)/ADAM-17. J. Biol. Chem. 2005, 280, 19543-19550.
110. Takano, A.; Ishikawa, N.; Nishino, R.; Masuda, K.; Yasui, W.; Inai, K.; Nishimura, H.; Ito, H.; Nakayama, H.; Miyagi, Y.; et al. Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer. Cancer Res. 2009, 69, 6694-6703.
111. Derycke, M.S.; Pambuccian, S.E.; Gilks, C.B.; Kalloger, S.E.; Ghidouche, A.; Lopez, M.; Bliss, R.L.; Geller, M.A.; Argenta, P.A.; Harrington, K.M. et al. Nectin 4 overexpression in ovarian cancer tissues and serum: Potential role as a serum biomarker. Am. J. Clin Pathol 2011, 134, 835-845.
112. Pavlova, N.N.; Pallasch, C.; Elia, A.E.; Braun, C.J.; Westbrook, T.F.; Hemann, M.; Elledge, S.J. A role for PVRL4-driven cell-cell interactions in tumorigenesis. Elife 2013, 2, e00358.
113. Sugiyama, T.; Yoneda, M.; Kuraishi, T.; Hattori, S.; Inoue, Y.; Sato, H.; Kai, C. Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment. Gene Ther. 2013, 20, 338-347.
114. Cao, L.; Si, J.; Wang, W.; Zhao, X.; Yuan, X.; Zhu, H.; Wu, X.; Zhu, J.; Shen, G. Intracellular localization and sustained prodrug cell killing activity of TAT-HSVTK fusion protein in hepatocelullar carcinoma cells. Mol. Cells 2006, 21, 104-111.
115. Fillat, C.; Carrio, M.; Cascante, A.; Sangro, B. Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application. Curr. Gene Ther. 2003, 3, 13-26.
116. Hermiston, T.W.; Kuhn, I. Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes. Cancer Gene Ther. 2002, 9, 1022-1035.
117. Hastie, E.; Grdzelishvili, V.Z., Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer. J. Gen. Virol. 2012, 93, 2529-2545.
118. Liu, Y.P.; Russell, S.P.; Ayala-Breton, C.; Russell, S.J.; Peng, K.W. Ablation of Nectin4 Binding Compromises CD46 Usage by a Hybrid Vesicular Stomatitis Virus/Measles Virus. J. Virol. 2014, 88, 2195-2204.
119. Naik, S.; Russell, S.J. Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways. Expert Opin. Biol. Ther. 2009, 9, 1163-1176.
120. Stojdl, D.F.; Lichty, B.; Knowles, S.; Marius, R.; Atkins, H.; Sonenberg, N.; Bell, J.C. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat. Med. 2000, 6, 821-825.
121. Diaz, R.M.; Galivo, F.; Kottke, T.; Wongthida, P.; Qiao, J.; Thompson, J.; Valdes, M.; Barber, G.; Vile, R.G. Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus. Cancer Res. 2007, 67, 2840-2848.
122. Grote, D.; Cattaneo, R.; Fielding, A.K. Neutrophils contribute to the measles virus-induced antitumor effect: enhancement by granulocyte macrophage colony-stimulating factor expression. Cancer Res. 2003, 63, 6463-6468.
123. Guillerme, J.B.; Boisgerault, N.; Roulois, D.; Menager, J.; Combredet, C.; Tangy, F.; Fonteneau, J.F.; Gregoire, M. Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells. Clin. Cancer Res. 2013, 19, 1147-58.
124. Ong, H.T.; Hasegawa, K.; Dietz, A.B.; Russell, S.J.; Peng, K.W. Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies. Gene Ther. 2007, 14, 324-333.
125. Miest, T.S.; Cattaneo, R., New viruses for cancer therapy: meeting clinical needs. Nat. Rev. Microbiol. 2014, 12, 23-34.